Tuesday, January 29, 2008

Eli Lilly: set to move into the neurology sector

Eli Lilly: set to move into the neurology sector
Trading Markets (press release) - Los Angeles,CA,USA
Datamonitor anticipates the launch of MBP8298 for SPMS in the EU in H1 2011 and H1 2012 in the US. With the additional approval for RRMS expected by the end ...
See all stories on this topic

Acorda Therapeutics Announces Successful Thorough QT Study of ...
Centre Daily Times - Centre,PA,USA
HAWTHORNE, NY — Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced results from a thorough QT study of Fampridine-SR. This study evaluated the ...
See all stories on this topic

Positive Data for Genentech, Biogen's Rituxan
TheStreet.com - USA
More data on Rituxan could emerge in the first half of 2008 from the Olympus study in PPMS and the Explorer study in lupus. "Today's trial announcement for ...
See all stories on this topic

US Federal Trade Commission clears global licensing and ...
CNW Telbec (Communiqués de presse) - Montréal,Québec,Canada
Under the terms of the agreement, Lilly and BioMS will collaborate on the development of MBP8298 and will also share in certain development costs, ...
See all stories on this topic

Firefighter loses his battle with leukemia
Aurora Beacon News - Aurora,IL,USA
I explained to him that my 35-year-old sister was stricken with multiple sclerosis several years ago and, like Marco, is a true warrior. ...
See all stories on this topic

Committee considers stem cell research bill
El Defensor Chieftain - Socorro,NM,USA
Miler has multiple sclerosis and said she "wouldn't take a cell that is from a potential baby and have it used on me to make me well. ...
See all stories on this topic

Medical breakthrough amazes doctors
KETK - Longview,TX,USA
Doctors believe this breakthrough will benefit transplant medicine, and other auto immune diseases like Type-one Diabetes and Multiple Sclerosis.
See all stories on this topic

Cody Unser, favoring stem cell bill, says walking 'political'
Alamogordo Daily News - Alamogordo,NM,USA
Supporters say thousands of New Mexicans who suffer from diseases such as Parkinson's, multiple sclerosis, and diabetes could potentially benefit from such ...
See all stories on this topic

Amalgam Fillings Don't Affect Children's Brain Development, Says Study In ADA Journal
Dental amalgam tooth fillings do not adversely affect children's brain development and neurological status, researchers report in the February issue of The Journal of the American Dental Association.


Post a Comment

Links to this post:

Create a Link

<< Home